Skip to main content Accessibility help
×
Home

Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk

  • Esther C Janowsky (a1), Gayle E Lester (a2), Clarice R Weinberg (a3), Robert C Millikan (a1), Joellen M Schildkraut (a4), Peter A Garrett (a1) and Barbara S Hulka (a1)...

Abstract

Objective

To determine if blood levels of 25-hydroxyvitamin D (25-D) or its active metabolite, 1,25-dihydroxyvitamin D (1,25-D), are lower in women at the time of first diagnosis of breast cancer than in comparable women without breast cancer.

Design

This was a clinic-based case–control study with controls frequency-matched to cases on race, age, clinic and month of blood drawing.

Setting

University-based breast referral clinics.

Subjects

One hundred and fifty-six women with histologically documented adenocarcinoma of the breast and 184 breast clinic controls.

Results

There were significant mean differences in 1,25-D levels (pmol ml−1) between breast cancer cases and controls; white cases had lower 1,25-D levels than white controls (mean difference ± SE: −11.08 ± 0.76), and black cases had higher 1,25-D levels than black controls (mean difference ± SE: 4.54 ± 2.14), although the number of black women in the study was small. After adjustment for age, assay batch, month of blood draw, clinic and sample storage time, the odds ratio (95% confidence interval, CI) for lowest relative to highest quartile was 5.2 (95% CI 2.1, 12.8) for white cases and controls. The association in white women was stronger in women above the median age of 54 than in younger women, 4.7 (95% CI 2.1, 10.2) vs. 1.5 (95% CI 0.7, 3.0). There were no case–control differences in 25-D levels in either group.

Conclusions

These data are consistent with a protective effect of 1,25-D for breast cancer in white women.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk
      Available formats
      ×

Copyright

Corresponding author

*Corresponding author: Email esther_janowsky@unc.edu

References

Hide All
1DeLuca, HF, Ostrem, V. The relationship between the vitamin D system and cancer. Adv. Exp. Med. Biol. 1987; 206: 413–29.
2Reichel, H, Koeffler, HP, Norman, AW. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 1989; 320: 980–91.
3Manoglas, SC. Vitamin D and its relevance to cancer. AntiCancer Res. 1987; 7: 625–38.
4Studzinski, GP, Moore, DC. Sunlight—can it prevent as well as cause cancer? Cancer Res. 1995; 55: 4014–22.
5Gorham, ED, Garland, FC, Garland, CF. Sunlight and breast cancer incidence in the USSR. Int. J. Epidemiol. 1990; 19: 820–4.
6Garland, FC, Garland, CF, Gorham, ED, Young, JF. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med. 1990; 19: 614–22.
7Blot, WJ, Fraumeni, JF, Stone, BJ. Geographic patterns of breast cancer in the United States. J. Natl. Cancer Inst. 1977; 59: 1407–11.
8Simard, A, Vobecky, J, Vobecky, JS. Vitamin D deficiency and cancer of the breast: an unprovocative ecological hypothesis. Can. J. Public Health 1991; 82: 300–3.
9Chouvet, C, Vicard, E, Devonec, M, Saez, S. 1,25-dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J. Steroid Biochem. 1986; 24: 373–6.
10Frappart, L, Falette, N, Lefebvre, MF, Bremond, A, Vauzelle, JL, Saez, S. In vitro studies of effects of 1,25-dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT-20. Differentiation 1989; 40: 63–9.
11Welsh, J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem. Cell Biol. 1994; 72: 537–47.
12James, SY, Mackay, AG, Colston, KW. Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J. Mol. Endocrinol. 1995; 14: 391–4.
13Tsoukas, CD, Provvedini, DM, Manolagas, SC. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984; 224(4656): 1438–40.
14Reinhardt, TA, Ramberg, CF, Horst, RL. Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and its 24 epimer. Arch. Biochem. Biophys. 1989; 273: 6471.
15Nemere, I, Yoshimoto, Y, Norman, AW. Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology 1984; 115: 1476–83.
16Krishnan, AV, Feldman, D. Stimulation of 1,25-dihydroxyvitamin D3 receptor gene expression in cultured cells by serum and growth factors. J. Bone Miner. Res. 1991; 6: 1099–107.
17Love, RR, Mazess, RB, Barden, HS, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N. Engl. J. Med. 1992; 326: 852–6.
18Holick, MF. The use and interpretation of assays for vitamin D and its metabolites. J. Nutr. 1990; 120: 1464–9.
19Mawer, EB, Walls, J, Howell, A, Davies, M, Ratcliffe, WA, Bundred, NJ. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer with bone metastases. J. Clin. Endocrinol. Metab. 1997; 82: 118–22.
20Elledge, RM, Clark, GM, Chamness, GC, Osborne, CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J. Natl. Cancer Inst. 1994; 86: 705–12.
21Abrams, SA, O'Brien, KO, Liang, LK, Stuff, JE. Differences in calcium absorption and kinetics between black and white girls aged 5–16 years. J. Bone Miner. Res. 1995; 10: 829–33.
22Meier, DE, Luckey, MM, Wallenstein, S, Clemens, TL, Orwoll, ES, Waslien, CI. Calcium, vitamin D, and parathyroid hormone status in young white and black women: association with racial differences in bone mass. J. Clin. Endocrinol. Metab. 1991; 72: 703–10.
23M'Buyamba-Kabangu, JR, Fagard, R, Lijnen, P, Bouillon, R, Lissens, W, Amery, A. Calcium, vitamin D–endocrine system, and parathyroid hormone in black and white males. Calcif. Tissue Int. 1987; 41: 70–4.
24Reasner, CA, Dunn, JF, Fetchik, DA, et al. Alteration of vitamin D metabolism in Mexican-Americans. J. Bone Miner. Res. 1990; 5: 1317.
25Bell, NH, Greene, A, Epstein, S, Oexmann, MJ, Shaw, S, Shary, J. Evidence for alteration of the vitamin D–endocrine system in blacks. J. Clin. Invest. 1985; 76: 470–3.
26Loomis, F. Skin-pigment regulation of vitamin D biosynthesis in man. Science 1967; 157: 501–6.
27Hiatt, RA, Krieger, N, Lobaugh, B, Drezner, MK, Vogelman, JH, Orentreich, N. Prediagnostic serum vitamin D and breast cancer. J. Natl. Cancer Inst. 1998; 90: 461–3.
28Garrett, PA, Hulka, BS, Kim, YL, Farber, RA. HRAS proto-oncogene polymorphism and breast cancer. Cancer Epidemiol. Biomark. Prev. 1993; 2: 131–8.
29Hosmer, DW, Lemeshow, S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
30SAS Companion for the Microsoft Windows Environment, version 6. Cary, NC: SAS Institute Inc., 1993.
31Breslow, NE, Day, NE. Statistical Methods in Cancer Research, Vol. I. The Analysis of Case–Control Studies. Lyon: International Agency for Research on Cancer, 1980.
32Harris, JR, Lippman, ME, Veronesi, U, Willet, W. Breast cancer. N. Engl. J. Med. 1992; 327: 319–28.
33Bouillon, RA, Auwerx, JH, Lissens, WD, Pelemens, WK. Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-hydroxyvitamin cholecalciferol deficiency. Am. J. Clin. Nutr. 1987; 45: 755–63.
34Sherman, SS, Hollis, BW, Tobin, JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J. Clin. Endocrinol. Metab. 1990; 71: 405–13.
35Cantatore, FP, Carrozzo, M, Magle, DM, D'Amore, M, Pipitone, V. Serum 1,25(OH)2D in the elderly and osteoporotic subjects from southern Italy. In: Norman, AW, Schafer, K, Grigoleit, H-G, Herrath, DV, eds. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Proceedings of the Seventh Workshop on Vitamin D. New York: Walter de Gruyter & Co., 1988; 897–8.
36Halloran, BP, Portale, AA, Lonergan, ET, Morris, RC Jr. Production and metabolic clearance of 1,25-dihydroxyvitamin D in men: effect of advancing age. J. Clin. Endocrinol. Metab. 1990; 70: 318–23.
37Tsai, KS, Wahner, HW, Offord, KP, Melton, LJ III, Kumar, RRiggs, BL. Effect of aging on vitamin D stores and bone density in women. Calcif. Tissue Int. 1987; 40: 241–3.
38Gloth, FM III, Gundberg, CM, Hollis, BW, Haddad, JG, Tobin, JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995; 274: 1683–6.
39Leaver, DD, Trechsel, U, Fleisch, H. How is plasma 1,25(OH)2D3 concentration regulated by dietary calcium? In: Norman, AW, Schafer, K, Grigoleit, H-G, Herrath, DV, eds. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Proceedings of the Seventh Workshop on Vitamin D. New York: Walter de Gruyter & Co., 1988; 662–3.
40Weiss, NS, Liff, JM. Accounting for the multicausal nature of disease in the design and analysis of epidemiologic studies. Am. J. Epidemiol. 1983; 117: 1418.
41Webb, R, Pilbeam, C, Hanafin, N, Holick, M. An evaluation of the relative contribution of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am. J. Clin. Nutr. 1990; 51: 1075–81.
42Tsai, KS, Heath, H III, Kumar, R, Riggs, BL. Impaired vitamin D metabolism with aging in women. J. Clin. Invest. 1984; 73: 1668–72.
43Colston, KW, Berger, U, Coombes, RC. Possible role for vitamin D in controlling breast cell proliferation. Lancet 1989: 1: 188–91.
44Lieberman, UA. Inborn errors in vitamin D metabolism—their contributions to the understanding of vitamin D metabolism. In: Norman, AW, Schafer, K, Grigoleit, H-G, Herrath, DV, eds. Vitamin D: Molecular, Cellular and Clinical Endocrinology. Proceedings of the Seventh Workshop on Vitamin D. New York: Walter de Gruyter & Co., 1988; 935–47.
45Taylor, JA, Hirvonen, A, Watson, M, Pittman, G, Mohler, JL, Bell, DA. Association of, prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996; 56: 4108–10.
46Ikekawa, N. Structures and biological activities of vitamin D metabolites and their analog. Med. Res. Rev. 1987; 7: 333–66.
47Matsumoto, T. Cell differentiation and vitamin D. Nippon Naibunpi Gakki Zasshi 1992; 68(5): 526–37.
48Mehta, RG, Moriarty, RM, Mehta, RR, et al. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1a-hydroxyvitamin D5. J. Natl. Cancer. Inst. 1997; 89: 212–18.

Keywords

Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk

  • Esther C Janowsky (a1), Gayle E Lester (a2), Clarice R Weinberg (a3), Robert C Millikan (a1), Joellen M Schildkraut (a4), Peter A Garrett (a1) and Barbara S Hulka (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed